Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Mild to Moderate COVID-19: early-phase trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Mild to Moderate COVID-19: 1 US clinical trial tracked, none currently recruiting.

Mild to Moderate COVID-19 is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Oneness Biotech Co., running 1 of these trials.

Enrollment posture brief

Registry condition mild-to-moderate-covid-19

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Mild to Moderate COVID-1 (th…0%
Open-enrollment share among volume-matched conditions near Mild to Moderate COVID-19

Mild to Moderate COVID-19 has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Mild to Moderate COVID-19 on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Mild to Moderate COVID-19 is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Mild to Moderate COVID-19 records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

MBS-COV Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Mild to Moderate COVID-19 trials. A trial with sites in several states counts in each.

Utah 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Mild to Moderate COVID-19 page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Mild to Moderate COVID-19 trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Oneness Biotech Co. sponsors the most Mild to Moderate COVID-19 trials on record, review their full trial history before evaluating a specific study. See Oneness Biotech Co.'s trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Mild to Moderate COVID-19 condition card totals 1 registered trials; most-linked intervention MBS-COV; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.